Pipeline

Pioneering Treg-Targeted Therapies

Our broad pipeline combines three therapeutic modalities targeting Treg dysfunction:
Treg modifying biologics, allogeneic Treg-derived exosomes, and autologous Treg cell therapy.

COYA 302 Program

Other Treg Enhancing Therapeutics